论文部分内容阅读
美国纽约州立大学的:Joseph G.Feldman 博士在近期的《美国公共卫生杂志》(AJPH)上指出,在接受高效抗逆转录病毒治疗(HAART)的女性 HIV感染者中,吸烟者的预后与不吸烟者相比较差,同时更容易发生免疫重建失败。研究发现吸烟的 HIV 感染者的预后差于不吸烟患者;Feldman 博士及其同事就吸烟对参加妇女多部门间 HIV 研究受试者的影响进行了分析。该研究系一项多点的纵向研究,评估对象为1994～1995年间登记的 HIV 感染女性;994名接受 HAART 的妇女的平均随访时间达到7.9年。吸烟者存在相当显著的高危险性;与不吸烟感染者相比,吸烟者体内的病毒对治疗反应较差,危
State University of New York: Dr. Joseph G. Feldman pointed out in a recent AJPH that the prognosis of smokers in non-HIV infected women who received HAART was similar to that of non-HIV infected women Smokers were poorer and were more likely to fail in immune reconstitution. The study found that the prevalence of HIV infection among smokers was worse than that of nonsmokers; Dr. Feldman and colleagues analyzed the impact of smoking on women participating in multisectoral HIV research. The study was a multi-point longitudinal study evaluating HIV-infected women registered between 1994 and 1995; 994 women with HAART had an average follow-up of 7.9 years. Smokers present a rather significant high risk; compared with non-smokers, smokers respond less well to treatment with the virus,